Skin science article
GHK-Cu Copper Peptide Studies — What the Research Shows
GHK-Cu Copper Peptide Studies — What the Research Shows GHK-Cu (Copper Peptide) Research: What the Studies Actually Show GHK-Cu is a naturally occurring copper-binding tripeptide with one of the richest cell-biology literatures in the peptide field. What the s
GHK-Cu Copper Peptide Studies — What the Research Shows
GHK-Cu (Copper Peptide) Research: What the Studies Actually Show
GHK-Cu is a naturally occurring copper-binding tripeptide with one of the richest cell-biology literatures in the peptide field. What the studies report on skin, gene expression, and repair — and what stays preclinical.
Research-use-only context. This article summarizes published third-party scientific literature — the large majority of it conducted in cultured cells or animal models. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. American Peptides products are sold strictly for in vitro laboratory research and are not for human or veterinary use.
GHK-Cu is unusual among research peptides for how deep its cell-biology literature runs. GHK (glycyl-L-histidyl-L-lysine) is a tripeptide first identified in human plasma; it binds copper(II) to form GHK-Cu, and its concentration declines with age. This summary surveys what the peer-reviewed studies report and where the evidence stops. For the format used across this series, see our BPC-157 research review.
What GHK-Cu is
GHK-Cu is a three-amino-acid sequence bound to a copper(II) ion. Copper binding is central to its studied biochemistry — a 2020 theoretical study examined exactly how the GHK sequence coordinates copper — and much of the research treats the copper complex, not the bare peptide, as the active species.
What the research reports
A widely cited 2015 review describes GHK as a “natural modulator of multiple cellular pathways in skin regeneration,” focusing on gene-expression modulation and extracellular-matrix remodeling; a 2020 review surveys GHK “as an anti-aging peptide.” The research is not limited to skin: a 2016 study reported GHK-Cu reduced lipopolysaccharide-induced acute lung injury in mice, and a 2015 orthopaedic study reported the complex “transiently improved healing outcome” in a rat model of ACL reconstruction — note the authors’ own word, transiently. These are cell and animal findings.
The human-evidence gap
The most rigorous GHK-Cu data are cell-based, animal, or topical-cosmetic. For the musculoskeletal and systemic uses that have made it popular, large controlled human trials are lacking — a point a 2026 Sports Medicine review on approved and unapproved peptide therapies makes directly. GHK-Cu is used in cosmetic products, but that is not the same as an approved therapeutic.
The takeaway
GHK-Cu has a rich, coherent literature in skin biology and gene modulation, with scattered work in other injury models. It is genuinely interesting cell biology — and, for systemic uses, still preclinical.
Frequently Asked Questions
What is GHK-Cu?
A copper-bound tripeptide (glycyl-histidyl-lysine plus copper(II)) found naturally in human plasma, studied mainly for skin-regeneration and gene-modulation research.
Why does GHK need copper?
Copper binding is central to its studied biochemistry; the GHK sequence has high affinity for copper(II), and research generally treats the copper complex as the active species.
Is GHK-Cu research only about skin?
Skin and gene expression is the richest area, but studies also span lung-injury and orthopaedic models — all preclinical or cosmetic.
Is GHK-Cu an approved therapeutic?
No. It appears in cosmetic and research contexts; American Peptides supplies it strictly for in vitro research.
Citations
Pickart L, Margolina A. “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.” Biomed Res Int. 2015;2015:648108. PubMed: PMID 26236730
Pickart L, et al. “The potential of GHK as an anti-aging peptide.” Aging Pathobiol Ther. 2020. PubMed: PMID 35083444
“Tripeptide-copper complex GHK-Cu(II) transiently improved healing outcome in a rat model of ACL reconstruction.” J Orthop Res. 2015. PubMed: PMID 25731775
Park JR, et al. “The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice.” Oncotarget. 2016. PubMed: PMID 27517151